Trends in the Design of Nucleoside Analogues as Anti-HIV Drugs

E-ISSN： 1873-4286|8|8|581-593

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.8, 2002-04, pp. : 581-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging anti-HIV drugs

By De Clercq Erik

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 241-274

Informa Healthcare

Access to resources Recommend Favorite

Design of Anti-HIV Compounds from Nucleoside to Nucleoside 5-Triphosphate Analogs. Problems and Perspectives

Current Pharmaceutical Design, Vol. 6, Iss. 5, 2000-03 ,pp. : 585-598

Bentham Science Publishers

Access to resources Recommend Favorite

Aminopyrimidinimino Isatin Analogues: Design and Synthesis of Novel Non- Nucleoside HIV-1 Reverse Transcriptase Inhibitors with Broad- Spectrum Anti-Microbial Properties

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 277-285

Bentham Science Publishers

Access to resources Recommend Favorite

Plant-derived Terpenoids and Analogues as Anti-HIV Agents

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 2, 2003-01 ,pp. : 155-169

Bentham Science Publishers

Access to resources Recommend Favorite

RNA as A Target for Host Defense and Anti-HIV Drugs

Current Drug Targets, Vol. 7, Iss. 12, 2006-12 ,pp. : 1607-1613

Bentham Science Publishers

Access to resources Recommend Favorite